SCHEDULE 13G/A: Bigger Capital Group Discloses 7.4% Stake in ClearPoint Neuro, Inc.
Beneficial Ownership Disclosure
An investment group led by Michael Bigger has disclosed a 7.4% beneficial ownership stake in ClearPoint Neuro, Inc. through an amended Schedule 13G filing.
Summary
- Bigger Capital Fund L P and Bigger Capital Fund GP, LLC each beneficially own 1,111,192 shares of ClearPoint Neuro, Inc. Common Stock, representing approximately 4.0% of the outstanding shares.
- District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, and District 2 Holdings LLC each beneficially own 418,942 shares, representing approximately 1.5% of the outstanding Common Stock.
- Michael Bigger, through various entities and personal holdings, beneficially owns an aggregate of 2,050,826 shares, which constitutes approximately 7.4% of the outstanding Common Stock.
- Michael Bigger's beneficial ownership includes 40,692 shares held in his IRA account, 162,000 shares owned by his spouse Patricia Winter, and 318,000 shares held by his sons.
- Patricia Winter holds 162,000 shares, which is reported as 0% of the outstanding Common Stock.
- The reported percentages are based on 27,584,699 shares of Common Stock outstanding as of October 31, 2024, as stated in the Company's Form 10-Q for the period ended September 30, 2024.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Michael Bigger's aggregate beneficial ownership includes shares held by his spouse, Patricia Winter (162,000 shares), and his sons (318,000 shares), indicating family-related holdings within the reported stake.
Stakeholder Impact
- Shareholders: Disclosure of significant institutional and individual ownership provides transparency regarding major investors and potential influence on corporate governance.
Key Dates
| Date | Description |
|---|---|
| 2024-10-31 | Date of shares outstanding calculation (27,584,699 shares) as per Company's Form 10-Q. |
| 2024-12-31 | Date of event which requires filing of this statement. |
| 2025-01-28 | Date as of which beneficial ownership amounts were calculated. |
| 2025-01-29 | Date of signing of the Schedule 13G Amendment No. 5. |
Keywords
ClearPoint Neuro, SEC filing, Schedule 13G, beneficial ownership, institutional ownership, investment fund, Bigger Capital, District 2 Capital, common stock, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.